Search

Your search keyword '"Peres, Lauren C."' showing total 220 results
Start Over Author "Peres, Lauren C." Search Limiters Full Text
220 results on '"Peres, Lauren C."'

1. Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association Consortium

Author

Meagher, Nicola S, White, Kami K, Wilkens, Lynne R, Bandera, Elisa V, Berchuck, Andrew, Carney, Michael E, Cramer, Daniel W, Cushing-Haugen, Kara L, Jordan, Susan, Kaufmann, Scott H, Le, Nhu D, Pike, Malcolm C, Riggan, Marjorie, Qin, Bo, Rothstein, Joseph H, Titus, Linda, Winham, Stacey J, Anton-Culver, Hoda, Doherty, Jennifer A, Goode, Ellen L, Pearce, Celeste Leigh, Risch, Harvey A, Webb, Penelope M, Cook, Linda S, Goodman, Marc T, Harris, Holly R, Le Marchand, Loic, McGuire, Valerie, Pharoah, Paul DP, Sarink, Danja, Schildkraut, Joellen M, Sieh, Weiva, Terry, Kathryn L, Thompson, Pamela J, Whittemore, Alice S, Wu, Anna H, Peres, Lauren C, and Merritt, Melissa A

Subjects
Epidemiology, Health Sciences, Ovarian Cancer, Rare Diseases, Cancer, Minority Health, Prevention, Women's Health, Humans, Female, Ovarian Neoplasms, Middle Aged, Carcinoma, Ovarian Epithelial, Risk Factors, Adult, Native Hawaiian or Other Pacific Islander, Case-Control Studies, Aged, Sterilization, Tubal, Parity, Asian, White People, Hispanic or Latino, United States, Contraceptives, Oral, Logistic Models, Smoking, Neoplasms, Glandular and Epithelial, Ethnicity, Odds Ratio, ovarian cancer, risk factors, race, ethnicity, Mathematical Sciences, Medical and Health Sciences
Abstract

Limited estimates exist on risk factors for epithelial ovarian cancer (EOC) in Asian, Hispanic, and Native Hawaiian/Pacific Islander women. Participants in this study included 1734 Asian (n = 785 case and 949 control participants), 266 Native Hawaiian/Pacific Islander (n = 99 case and 167 control participants), 1149 Hispanic (n = 505 case and 644 control participants), and 24 189 White (n = 9981 case and 14 208 control participants) from 11 studies in the Ovarian Cancer Association Consortium. Logistic regression models estimated odds ratios (ORs) and 95% CIs for risk associations by race and ethnicity. Heterogeneity in EOC risk associations by race and ethnicity (P ≤ .02) was observed for oral contraceptive (OC) use, parity, tubal ligation, and smoking. We observed inverse associations with EOC risk for OC use and parity across all groups; associations were strongest in Native Hawaiian/Pacific Islander and Asian women. The inverse association for tubal ligation with risk was most pronounced for Native Hawaiian/Pacific Islander participants (odds ratio (OR) = 0.25; 95% CI, 0.13-0.48) compared with Asian and White participants (OR = 0.68 [95% CI, 0.51-0.90] and OR = 0.78 [95% CI, 0.73-0.85], respectively). Differences in EOC risk factor associations were observed across racial and ethnic groups, which could be due, in part, to varying prevalence of EOC histotypes. Inclusion of greater diversity in future studies is essential to inform prevention strategies. This article is part of a Special Collection on Gynecological Cancers.

Published
2024

2. Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium

Author

Afrough, Aimaz, Hashmi, Hamza, Hansen, Doris K., Sidana, Surbhi, Ahn, Chul, Peres, Lauren C., Dima, Danai, Freeman, Ciara L., Puglianini, Omar Castaneda, Kocoglu, Mehmet H., Atrash, Shebli, Voorhees, Peter M., Shune, Leyla, McGuirk, Joseph P., Simmons, Gary, Sborov, Douglas W., Davis, James A., Kaur, Gurbakhash, Sannareddy, Aishwarya, Ferreri, Christopher J., Gaballa, Mahmoud R., Goldsmith, Scott, Nadeem, Omar, Midha, Shonali, Wagner, Charlotte B., Locke, Frederick L., Patel, Krina K., Khouri, Jack, Anderson, Jr., Larry D., and Lin, Yi

Published
2024
Full Text
View/download PDF

3. Menopausal hormone therapy use and risk of ovarian cancer by race: the ovarian cancer in women of African ancestry consortium

Author

Petrick, Jessica L., Joslin, Charlotte E., Johnson, Courtney E., Camacho, T. Fabian, Peres, Lauren C., Bandera, Elisa V., Barnard, Mollie E., Beeghly, Alicia, Bethea, Traci N., Dempsey, Lauren F., Guertin, Kristin, Harris, Holly R., Moorman, Patricia G., Myers, Evan R., Ochs-Balcom, Heather M., Rosenow, Will, Setiawan, V. Wendy, Wu, Anna H., Schildkraut, Joellen M., and Rosenberg, Lynn

Published
2023
Full Text
View/download PDF

4. Association of inflammation-related exposures and ovarian cancer survival in a multi-site cohort study of Black women

Author

Johnson, Courtney E., Alberg, Anthony J., Bandera, Elisa V., Peres, Lauren C., Akonde, Maxwell, Collin, Lindsay J., Cote, Michele L., Hastert, Theresa A., Hébert, James R., Peters, Edward S., Qin, Bonnie, Terry, Paul, Schwartz, Ann G., Bondy, Melissa, Epstein, Michael P., Mandle, Hannah B., Marks, Jeffrey R., Lawson, Andrew B., and Schildkraut, Joellen M.

Published
2023
Full Text
View/download PDF

5. Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy

Author

Ferreri, Christopher J., Hildebrandt, Michelle A. T., Hashmi, Hamza, Shune, Leyla O., McGuirk, Joseph P., Sborov, Douglas W., Wagner, Charlotte B., Kocoglu, M. Hakan, Rapoport, Aaron, Atrash, Shebli, Voorhees, Peter M., Khouri, Jack, Dima, Danai, Afrough, Aimaz, Kaur, Gurbakhash, Anderson, Jr., Larry D., Simmons, Gary, Davis, James A., Kalariya, Nilesh, Peres, Lauren C., Lin, Yi, Janakiram, Murali, Nadeem, Omar, Alsina, Melissa, Locke, Frederick L., Sidana, Surbhi, Hansen, Doris K., Patel, Krina K., and Castaneda Puglianini, Omar Alexis

Published
2023
Full Text
View/download PDF

6. Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy

Author

Peres, Lauren C., Oswald, Laura B., Dillard, Christen M., De Avila, Gabriel, Nishihori, Taiga, Blue, Brandon J., Freeman, Ciara L., Locke, Frederick L., Alsina, Melissa, Castaneda Puglianini, Omar, Shune, Leyla, Sborov, Douglas W., Wagner, Charlotte, Dima, Danai, Hashmi, Hamza, Davis, James A., Kocoglu, Mehmet H., Badros, Ashraf Z., Atrash, Shebli, Simmons, Gary, Kalariya, Nilesh, Ferreri, Christopher, Anderson, Larry D., Jr, Afrough, Aimaz, Kaur, Gurbakhash, Lin, Yi, Liu, Lawrence, Nadeem, Omar, Voorhees, Peter, Khouri, Jack, McGuirk, Joseph, Sidana, Surbhi, Hansen, Doris K., and Patel, Krina

Published
2024
Full Text
View/download PDF

7. Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma

Author

Lee, Dae Hyun, Kumar, Abhishek, Mohammed, Turab, Peres, Lauren C., Alsina, Melissa, Bachmeier, Christina, Blue, Brandon J., Brayer, Jason, Chandrasekhar, Sanjay, Grajales Cruz, Ariel, De Avila, Gabe, Elmariah, Hany, Faramand, Rawan, Freeman, Ciara, Jain, Michael, Khadka, Sushmita, Khimani, Farhad, Liu, Hien, Nishihori, Taiga, Oswald, Laura B., Castaneda Puglianini, Omar A., Shain, Kenneth H., Smith, Eric, Baz, Rachid C., Locke, Frederick L., Oliveira, Guilherme H., Alomar, Mohammed, and Hansen, Doris K.

Published
2023
Full Text
View/download PDF

8. Identification of novel epithelial ovarian cancer loci in women of African ancestry

Author

Manichaikul, Ani, Peres, Lauren C, Wang, Xin‐Qun, Barnard, Mollie E, Chyn, Deanna, Sheng, Xin, Du, Zhaohui, Tyrer, Jonathan, Dennis, Joseph, Schwartz, Ann G, Cote, Michele L, Peters, Edward, Moorman, Patricia G, Bondy, Melissa, Barnholtz‐Sloan, Jill S, Terry, Paul, Alberg, Anthony J, Bandera, Elisa V, Funkhouser, Ellen, Wu, Anna H, Pearce, Celeste Leigh, Pike, Malcom, Setiawan, Veronica Wendy, Haiman, Christopher A, Consortium, the African American Breast Cancer, Consortium, the African Ancestry Prostate Cancer, Palmer, Julie R, LeMarchand, Loic, Wilkens, Lynne R, Berchuck, Andrew, Doherty, Jennifer A, Modugno, Francesmary, Ness, Roberta, Moysich, Kirsten, Karlan, Beth Y, Whittemore, Alice S, McGuire, Valerie, Sieh, Weiva, Lawrenson, Kate, Gayther, Simon, Sellers, Thomas A, Pharoah, Paul, Schildkraut, Joellen M, and Consortium, the African American Cancer Epidemiology Study and the Ovarian Cancer Association

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Biotechnology, Cancer, Prevention, Ovarian Cancer, Rare Diseases, Genetics, Clinical Research, 2.1 Biological and endogenous factors, Aetiology, Black or African American, Aldo-Keto Reductase Family 1 Member C3, Antigens, Neoplasm, Black People, Breast Neoplasms, Carcinoma, Ovarian Epithelial, Female, Follistatin, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Neoplasm Proteins, Polymorphism, Single Nucleotide, United States, White People, ovarian cancer, African ancestry, genome wide association study, gene expression, eQTLs, African American Breast Cancer Consortium, African Ancestry Prostate Cancer Consortium, African American Cancer Epidemiology Study (AACES) and the Ovarian Cancer Association Consortium, Oncology & Carcinogenesis, Oncology and carcinogenesis
Abstract

Women of African ancestry have lower incidence of epithelial ovarian cancer (EOC) yet worse survival compared to women of European ancestry. We conducted a genome-wide association study in African ancestry women with 755 EOC cases, including 537 high-grade serous ovarian carcinomas (HGSOC) and 1,235 controls. We identified four novel loci with suggestive evidence of association with EOC (p

Published
2020

9. Predictors of survival trajectories among women with epithelial ovarian cancer

Author

Peres, Lauren C, Sinha, Sweta, Townsend, Mary K, Fridley, Brooke L, Karlan, Beth Y, Lutgendorf, Susan K, Shinn, Eileen, Sood, Anil K, and Tworoger, Shelley S

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Rare Diseases, Clinical Research, Ovarian Cancer, Prevention, Cancer, 2.4 Surveillance and distribution, Aetiology, Good Health and Well Being, Aged, Black People, Carcinoma, Ovarian Epithelial, Female, Humans, Middle Aged, Native Hawaiian or Other Pacific Islander, Neoplasm Staging, Ovarian Neoplasms, Prognosis, SEER Program, United States, White People, Ovarian cancer, Long-term survivors, Mortality, Histotype, Paediatrics and Reproductive Medicine, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis, Reproductive medicine
Abstract

ObjectiveAlthough ovarian cancer is a deadly disease, approximately a third of women survive ≥9 years after diagnosis. The factors associated with achieving long-term survival are not well understood. In this study, data from the Surveillance, Epidemiology, and End Results (SEER) program were used to determine predictors of survival trajectories among women with epithelial ovarian cancer and across histotype (high-grade serous carcinoma (HGSC) and non-HGSC).MethodsData on 35,868 women diagnosed with epithelial ovarian cancer in 2004-2016 were extracted from SEER. Extended Cox proportional hazards regression was used to estimate overall and histotype-specific associations between patient and tumor characteristics and all-cause mortality within each survival time (t) interval (t 70 years at diagnosis, where a high risk of mortality was observed in both the t

Published
2020

10. Racial differences in the association of body mass index and ovarian cancer risk in the OCWAA Consortium

Author

Ochs-Balcom, Heather M., Johnson, Courtney, Guertin, Kristin A., Qin, Bo, Beeghly-Fadiel, Alicia, Camacho, Fabian, Bethea, Traci N., Dempsey, Lauren F., Rosenow, Will, Joslin, Charlotte E., Myers, Evan, Moorman, Patricia G., Harris, Holly R., Peres, Lauren C., Wendy Setiawan, V., Wu, Anna H., Rosenberg, Lynn, Schildkraut, Joellen M., and Bandera, Elisa V.

Published
2022
Full Text
View/download PDF

11. Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Author

Logue, Jennifer M., Peres, Lauren C., Hashmi, Hamza, Colin-Leitzinger, Christelle M., Shrewsbury, Alexandria M., Hosoya, Hitomi, Gonzalez, Rebecca M., Copponex, Christina, Kottra, Krista H., Hovanky, Vanna, Sahaf, Bita, Patil, Sunita, Lazaryan, Aleksandr, Jain, Michael D., Baluch, Aliyah, Klinkova, Olga V., Bejanyan, Nelli, Faramand, Rawan G., Elmariah, Hany, Khimani, Farhad, Davila, Marco L., Mishra, Asmita, Blue, Brandon J., Grajales-Cruz, Ariel F., Castaneda Puglianini, Omar A., Liu, Hien D., Nishihori, Taiga, Freeman, Ciara L., Brayer, Jason B., Shain, Kenneth H., Baz, Rachid C., Locke, Frederick L., Alsina, Melissa, Sidana, Surbhi, and Hansen, Doris K.

Published
2022
Full Text
View/download PDF

12. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women

Author

Grant, Delores J, Manichaikul, Ani, Alberg, Anthony J, Bandera, Elisa V, Barnholtz‐Sloan, Jill, Bondy, Melissa, Cote, Michele L, Funkhouser, Ellen, Moorman, Patricia G, Peres, Lauren C, Peters, Edward S, Schwartz, Ann G, Terry, Paul D, Wang, Xin‐Qun, Keku, Temitope O, Hoyo, Cathrine, Berchuck, Andrew, Sandler, Dale P, Taylor, Jack A, O’Brien, Katie M, Edwards, Digna R Velez, Edwards, Todd L, Beeghly‐Fadiel, Alicia, Wentzensen, Nicolas, Pearce, Celeste Leigh, Wu, Anna H, Whittemore, Alice S, McGuire, Valerie, Sieh, Weiva, Rothstein, Joseph H, Modugno, Francesmary, Ness, Roberta, Moysich, Kirsten, Rossing, Mary Anne, Doherty, Jennifer A, Sellers, Thomas A, Permuth‐Way, Jennifer B, Monteiro, Alvaro N, Levine, Douglas A, Setiawan, Veronica Wendy, Haiman, Christopher A, LeMarchand, Loic, Wilkens, Lynne R, Karlan, Beth Y, Menon, Usha, Ramus, Susan, Gayther, Simon, Gentry‐Maharaj, Aleksandra, Terry, Kathryn L, Cramer, Daniel W, Goode, Ellen L, Larson, Melissa C, Kaufmann, Scott H, Cannioto, Rikki, Odunsi, Kunle, Etter, John L, Huang, Ruea‐Yea, Bernardini, Marcus Q, Tone, Alicia A, May, Taymaa, Goodman, Marc T, Thompson, Pamela J, Carney, Michael E, Tworoger, Shelley S, Poole, Elizabeth M, Lambrechts, Diether, Vergote, Ignace, Vanderstichele, Adriaan, Van Nieuwenhuysen, Els, Anton‐Culver, Hoda, Ziogas, Argyrios, Brenton, James D, Bjorge, Line, Salvensen, Helga B, Kiemeney, Lambertus A, Massuger, Leon FAG, Pejovic, Tanja, Bruegl, Amanda, Moffitt, Melissa, Cook, Linda, Le, Nhu D, Brooks‐Wilson, Angela, Kelemen, Linda E, Pharoah, Paul DP, Song, Honglin, Campbell, Ian, Eccles, Diana, DeFazio, Anna, Kennedy, Catherine J, and Schildkraut, Joellen M

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Biotechnology, Nutrition, Rare Diseases, Clinical Research, Genetics, Ovarian Cancer, Prevention, Cancer, 2.1 Biological and endogenous factors, Aetiology, Black or African American, Bayes Theorem, Carcinoma, Ovarian Epithelial, ErbB Receptors, Female, Genetic Association Studies, Glucuronosyltransferase, Humans, Logistic Models, Middle Aged, Neoplasm Grading, Ovarian Neoplasms, Polymorphism, Single Nucleotide, Receptors, Calcitriol, Vitamin D, African ancestry risk, genetic association, ovarian cancer, vitamin D pathway, Biochemistry and Cell Biology, Oncology and carcinogenesis
Abstract

An association between genetic variants in the vitamin D receptor (VDR) gene and epithelial ovarian cancer (EOC) was previously reported in women of African ancestry (AA). We sought to examine associations between genetic variants in VDR and additional genes from vitamin D biosynthesis and pathway targets (EGFR, UGT1A, UGT2A1/2, UGT2B, CYP3A4/5, CYP2R1, CYP27B1, CYP24A1, CYP11A1, and GC). Genotyping was performed using the custom-designed 533,631 SNP Illumina OncoArray with imputation to the 1,000 Genomes Phase 3 v5 reference set in 755 EOC cases, including 537 high-grade serous (HGSOC), and 1,235 controls. All subjects are of African ancestry (AA). Logistic regression was performed to estimate odds ratios (OR) and 95% confidence intervals (CI). We further evaluated statistical significance of selected SNPs using the Bayesian False Discovery Probability (BFDP). A significant association with EOC was identified in the UGT2A1/2 region for the SNP rs10017134 (per allele OR = 1.4, 95% CI = 1.2-1.7, P = 1.2 × 10-6 , BFDP = 0.02); and an association with HGSOC was identified in the EGFR region for the SNP rs114972508 (per allele OR = 2.3, 95% CI = 1.6-3.4, P = 1.6 × 10-5 , BFDP = 0.29) and in the UGT2A1/2 region again for rs1017134 (per allele OR = 1.4, 95% CI = 1.2-1.7, P = 2.3 × 10-5 , BFDP = 0.23). Genetic variants in the EGFR and UGT2A1/2 may increase susceptibility of EOC in AA women. Future studies to validate these findings are warranted. Alterations in EGFR and UGT2A1/2 could perturb enzyme efficacy, proliferation in ovaries, impact and mark susceptibility to EOC.

Published
2019

13. Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma

Author

Peres, Lauren C., Colin-Leitzinger, Christelle M., Teng, Mingxiang, Dutil, Julie, Alugubelli, Raghunandan R., DeAvila, Gabriel, Teer, Jamie K., Du, Dongliang, Mo, Qianxing, Siegel, Erin M., Hampton, Oliver A., Alsina, Melissa, Brayer, Jason, Blue, Brandon, Baz, Rachid, Silva, Ariosto S., Nishihori, Taiga, Shain, Kenneth H., and Gillis, Nancy

Published
2022
Full Text
View/download PDF

14. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.

Author

Peres, Lauren C, Risch, Harvey, Terry, Kathryn L, Webb, Penelope M, Goodman, Marc T, Wu, Anna H, Alberg, Anthony J, Bandera, Elisa V, Barnholtz-Sloan, Jill, Bondy, Melissa L, Cote, Michele L, Funkhouser, Ellen, Moorman, Patricia G, Peters, Edward S, Schwartz, Ann G, Terry, Paul D, Manichaikul, Ani, Abbott, Sarah E, Camacho, Fabian, Jordan, Susan J, Nagle, Christina M, Australian Ovarian Cancer Study Group, Anne Rossing, Mary, Doherty, Jennifer A, Modugno, Francesmary, Moysich, Kirsten, Ness, Roberta, Berchuck, Andrew, Cook, Linda, Le, Nhu, Brooks-Wilson, Angela, Sieh, Weiva, Whittemore, Alice, McGuire, Valerie, Rothstein, Joseph, Anton-Culver, Hoda, Ziogas, Argyrios, Pearce, Celeste L, Tseng, Chiuchen, Pike, Malcom, Schildkraut, Joellen M, and African American Cancer Epidemiology Study and the Ovarian Cancer Association Consortium

Subjects
Australian Ovarian Cancer Study Group, African American Cancer Epidemiology Study and the Ovarian Cancer Association Consortium, Statistics, Public Health and Health Services, Epidemiology
Published
2018

15. Abstract B037: Physical inactivity is associated with ovarian cancer in women of African ancestry

Author

Minlikeeva, Albina, primary, Lima, Sarah M., additional, Johnson, Courtney, additional, Bandera, Elisa V., additional, Beeghly-Fadiel, Alicia, additional, Bethea, Traci N., additional, Petrick, Jessica, additional, Joslin, Charlotte E., additional, Myers, Evan, additional, Harris, Holly R., additional, Peres, Lauren C., additional, Setiawan, V. Wendy, additional, Wu, Anna H., additional, Rosenberg, Lynn, additional, Schildkraut, Joellen M., additional, and Ochs-Balcom, Heather M., additional

Published
2024
Full Text
View/download PDF

17. The Association between Mediated Deprivation and Ovarian Cancer Survival among African American Women

Author

Lawson, Andrew B., primary, Kim, Joanne, additional, Johnson, Courtney, additional, Ratnapradipa, Kendra L., additional, Alberg, Anthony J., additional, Akonde, Maxwell, additional, Hastert, Theresa, additional, Bandera, Elisa V., additional, Terry, Paul, additional, Mandle, Hannah, additional, Cote, Michele L., additional, Bondy, Melissa, additional, Marks, Jeffrey, additional, Peres, Lauren C., additional, Schildkraut, Joellen, additional, and Peters, Edward S., additional

Published
2023
Full Text
View/download PDF

18. Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel

Author

Oswald, Laura B., primary, Gudenkauf, Lisa M., additional, Li, Xiaoyin, additional, De Avila, Gabriel, additional, Peres, Lauren C., additional, Kirtane, Kedar, additional, Gonzalez, Brian D., additional, Hoogland, Aasha I., additional, Nguyen, Oanh, additional, Rodriguez, Yvelise, additional, Baz, Rachid C., additional, Shain, Kenneth H., additional, Alsina, Melissa, additional, Locke, Frederick L., additional, Freeman, Ciara, additional, Castaneda Puglianini, Omar, additional, Nishihori, Taiga, additional, Liu, Hien, additional, Blue, Brandon, additional, Grajales-Cruz, Ariel, additional, Jim, Heather S. L., additional, and Hansen, Doris K., additional

Published
2023
Full Text
View/download PDF

21. Associations between Patient-Reported Outcomes and 90-Day Response to Chimeric Antigen Receptor T-Cell Therapy: A Bayesian Network Analysis

Author

Oswald, Laura B., primary, Luo, Yi, additional, Li, Xiaoyin, additional, Hoogland, Aasha I., additional, Gonzalez, Brian D., additional, Hansen, Doris K., additional, Jain, Michael D., additional, Locke, Frederick L., additional, Peres, Lauren C., additional, Kirtane, Kedar, additional, El Naqa, Issam, additional, and Jim, Heather S.L., additional

Published
2022
Full Text
View/download PDF

22. Patterns of Relapse and Clinical Outcomes in Multiple Myeloma Patients after Anti-BCMA CAR T-Cell Therapy: Implications for Patient's Monitoring after CAR T-Cell Therapy

Author

Castaneda Puglianini, Omar Alexis, primary, Peres, Lauren C., additional, Hansen, Doris K., additional, Nishihori, Taiga, additional, Grajales-Cruz, Ariel F, additional, Blue, Brandon J., additional, Brayer, Jason, additional, Freeman, Ciara L., additional, Shain, Kenneth H., additional, Liu, Hien D., additional, Ochoa, Jose, additional, Locke, Frederick L., additional, Baz, Rachid C., additional, and Alsina, Melissa, additional

Published
2022
Full Text
View/download PDF

23. Idecabtagene Vicleucel (Ide-cel) Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Who Have Received a Prior BCMA-Targeted Therapy: Real World, Multi-Institutional Experience

Author

Ferreri, Christopher J., primary, Hildebrandt, Michelle A.T., additional, Hashmi, Hamza, additional, Shune, Leyla O., additional, McGuirk, Joseph P., additional, Sborov, Douglas W., additional, Wagner, Charlotte B, additional, Kocoglu, M. Hakan, additional, Atrash, Shebli, additional, Voorhees, Peter M., additional, Khouri, Jack, additional, Dima, Danai, additional, Afrough, Aimaz, additional, Sannareddy, Aishwarya, additional, Simmons, Gary, additional, Davis, James, additional, Kalariya, Nilesh, additional, Peres, Lauren C., additional, Alsina, Melissa, additional, Locke, Frederick L., additional, Sidana, Surbhi, additional, Hansen, Doris K., additional, Patel, Krina, additional, and Castaneda Puglianini, Omar Alexis, additional

Published
2022
Full Text
View/download PDF

24. Factors Associated with Refractoriness or Early Progression after Idecabtagene Vicleucel (Ide-cel) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): U.S. Myeloma CAR T Consortium Real World Experience

Author

Hashmi, Hamza, primary, Hansen, Doris K., additional, Peres, Lauren C., additional, Castaneda Puglianini, Omar Alexis, additional, Freeman, Ciara L., additional, De Avila, Gabriel, additional, Sidana, Surbhi, additional, Shune, Leyla O., additional, Sborov, Douglas W., additional, Davis, James, additional, Wagner, Charlotte B., additional, Kocoglu, M. Hakan, additional, Atrash, Shebli, additional, Voorhees, Peter M., additional, Simmons, Gary, additional, Ferreri, Christopher J., additional, Kalariya, Nilesh, additional, Sannareddy, Aishwarya, additional, Dima, Danai, additional, Khouri, Jack, additional, McGuirk, Joseph P., additional, Locke, Frederick L., additional, Baz, Rachid C., additional, Patel, Krina, additional, and Alsina, Melissa, additional

Published
2022
Full Text
View/download PDF

25. Racial and Ethnic Differences in Clinical Outcomes Among Multiple Myeloma Patients Treated with CAR T Therapy

Author

Peres, Lauren C., primary, Oswald, Laura B., additional, Dillard, Christen, additional, De Avila, Gabriel, additional, Nishihori, Taiga, additional, Blue, Brandon J., additional, Freeman, Ciara L., additional, Locke, Frederick L., additional, Alsina, Melissa, additional, Castaneda Puglianini, Omar Alexis, additional, Shune, Leyla O., additional, Sborov, Douglas W., additional, Wagner, Charlotte B, additional, Dima, Danai, additional, Hashmi, Hamza, additional, Davis, James, additional, Kocoglu, M. Hakan, additional, Atrash, Shebli, additional, Simmons, Gary, additional, Kalariya, Nilesh, additional, Ferreri, Christopher J., additional, Sannareddy, Aishwarya, additional, Afrough, Aimaz, additional, Voorhees, Peter M., additional, Khouri, Jack, additional, McGuirk, Joseph P., additional, Sidana, Surbhi, additional, Hansen, Doris K., additional, and Patel, Krina, additional

Published
2022
Full Text
View/download PDF

26. Absolute Lymphocyte Count and Outcomes of Multiple Myeloma Patients Treated with Idecabtagene Vicleucel: The U.S. Myeloma CAR T Consortium Real World Experience

Author

Khouri, Jack, primary, Li, Hong, additional, Hansen, Doris K., additional, Sidana, Surbhi, additional, Shune, Leyla O., additional, DeJarnette, Shaun, additional, Anwer, Faiz, additional, Sborov, Douglas W, additional, Wagner, Charlotte B, additional, Kocoglu, M. Hakan, additional, Atrash, Shebli, additional, Voorhees, Peter M., additional, Valent, Jason, additional, Peres, Lauren C., additional, Hovanky, Vanna, additional, Simmons, Gary, additional, Dima, Danai, additional, Kalariya, Nilesh, additional, Afrough, Aimaz, additional, Kaur, Gurbakhash, additional, Sannareddy, Aishwarya, additional, Ferreri, Christopher J., additional, Davis, James, additional, McGuirk, Joseph P., additional, Locke, Frederick L., additional, Baz, Rachid C., additional, Hamilton, Betty K., additional, Alsina, Melissa, additional, Sauter, Craig S., additional, Hashmi, Hamza, additional, and Patel, Krina, additional

Published
2022
Full Text
View/download PDF

27. Baseline Systemic Inflammatory Markers Interleukin 6 and Ferritin Are Associated with Toxicities and Progression-Free Survival in Multiple Myeloma Patients Treated with Idecabtagene Vicleucel

Author

Hansen, Doris K., primary, Peres, Lauren C., additional, Freeman, Ciara L., additional, Castaneda Puglianini, Omar Alexis, additional, Faramand, Rawan, additional, Oswald, Laura B., additional, Reid, Kayla M., additional, De Avila, Gabriel, additional, Blue, Brandon J., additional, Grajales-Cruz, Ariel F., additional, Ochoa, Jose, additional, Shrewsbury, Alexandria, additional, Powell, Cole T., additional, Copponex, Christina, additional, Kottra, Krista H., additional, Gonzalez, Rebecca, additional, Logue, Jennifer M., additional, Khimani, Farhad, additional, Elmariah, Hany, additional, Jain, Michael D., additional, Nishihori, Taiga, additional, Liu, Hien D., additional, Brayer, Jason, additional, Shain, Ken H., additional, Baz, Rachid, additional, Locke, Frederick L., additional, Alsina, Melissa, additional, and Davila, Marco L., additional

Published
2022
Full Text
View/download PDF

28. Idecabtagene Vicleucel Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma with Renal Insufficiency: Real World Experience

Author

Sidana, Surbhi, primary, Peres, Lauren C., additional, Hashmi, Hamza, additional, Hosoya, Hitomi, additional, Ferreri, Christopher J., additional, Atrash, Shebli, additional, Khouri, Jack, additional, Voorhees, Peter M., additional, Dima, Danai, additional, Simmons, Gary, additional, Kalariya, Nilesh, additional, Hovanky, Vanna, additional, Bharadwaj, Sushma, additional, Arai, Sally, additional, Miklos, David B., additional, Wagner, Charlotte B, additional, Davis, James, additional, Sborov, Douglas W., additional, Nishihori, Taiga, additional, Alsina, Melissa, additional, Locke, Frederick L., additional, Gonzalez, Rebecca, additional, Kocoglu, M. Hakan, additional, Sannareddy, Aishwarya, additional, Afrough, Aimaz, additional, McGuirk, Joseph P., additional, Shune, Leyla O., additional, Patel, Krina, additional, and Hansen, Doris K., additional

Published
2022
Full Text
View/download PDF

29. Abstract 3218: Radiomic biomarkers to optimize treatment decision and predict patient outcomes in serous ovarian carcinoma

Author

Perez-Morales, Jaileene, primary, Leitzinger, Christelle M. Colin, additional, Sinha, Sweta K., additional, McGettigan, Melissa J., additional, Jeong, Daniel K., additional, Stringfield, Olya, additional, Abdala, Mahmoud, additional, Raghunand, Natarajan, additional, Gillies, Robert J., additional, Chern, Jing-Yi, additional, Peres, Lauren C., additional, and Schabath, Matthew B., additional

Published
2022
Full Text
View/download PDF

31. Abstract 5886: Pre-treatment adiposity measured by computed tomography and survival of women with high-grade serous ovarian cancer

Author

Colin-Leitzinger, Christelle, primary, Jeong, Daniel, additional, Abdalah, Mahmoud, additional, Cannioto, Rikki, additional, Chern, Jing-Yi, additional, Davis, Evan, additional, Gillies, Robert, additional, McGettigan, Melissa, additional, Perez-Morales, Jaileene, additional, Raghunand, Natarajan, additional, Sinha, Sweta, additional, Stringfield, Olya, additional, Tirbene, Rajwantee, additional, Schabath, Matthew, additional, and Peres, Lauren C., additional

Published
2022
Full Text
View/download PDF

32. Race Differences in the Associations between Menstrual Cycle Characteristics and Epithelial Ovarian Cancer

Author

Nash, Rebecca, primary, Johnson, Courtney E., additional, Harris, Holly R., additional, Peres, Lauren C., additional, Joslin, Charlotte E., additional, Bethea, Traci N., additional, Bandera, Elisa V., additional, Ochs-Balcom, Heather M., additional, Myers, Evan R., additional, Guertin, Kristin A., additional, Camacho, Fabian, additional, Beeghly-Fadiel, Alicia, additional, Moorman, Patricia G., additional, Setiawan, V. Wendy, additional, Rosenberg, Lynn, additional, Schildkraut, Joellen M., additional, and Wu, Anna H., additional

Published
2022
Full Text
View/download PDF

34. Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian Carcinoma

Author

Peres, Lauren C., primary, Colin-Leitzinger, Christelle, additional, Sinha, Sweta, additional, Marks, Jeffrey R., additional, Conejo-Garcia, Jose R., additional, Alberg, Anthony J., additional, Bandera, Elisa V., additional, Berchuck, Andrew, additional, Bondy, Melissa L., additional, Christensen, Brock C., additional, Cote, Michele L., additional, Doherty, Jennifer Anne, additional, Moorman, Patricia G., additional, Peters, Edward S., additional, Moran Segura, Carlos, additional, Nguyen, Jonathan V., additional, Schwartz, Ann G., additional, Terry, Paul D., additional, Wilson, Christopher M., additional, Fridley, Brooke L., additional, and Schildkraut, Joellen M., additional

Published
2022
Full Text
View/download PDF

35. Diet and Survival in Black Women With Epithelial Ovarian Cancer.

Author

Armidie, Tsion A., Bandera, Elisa V., Johnson, Courtney E., Peres, Lauren C., Haller, Kristin, Terry, Paul, Akonde, Maxwell, Peters, Edward S., Cote, Michele L., Hastert, Theresa A., Collin, Lindsay J., Epstein, Michael, Marks, Jeffrey, Bondy, Melissa, Lawson, Andrew B., Alberg, Anthony J., Schildkraut, Joellen M., and Qin, Bo

Published
2024
Full Text
View/download PDF

36. Racial and Ethnic Differences in Clonal Hematopoiesis, Tumor Markers, and Clinical Outcomes of Patients with Multiple Myeloma

Author

Gillis, Nancy, primary, Peres, Lauren C, additional, Colin-Leitzinger, Christelle M, additional, Teng, Mingxiang, additional, Alugubelli, Raghunandan Reddy, additional, De Avila, Gabriel, additional, Du, Dongliang, additional, Siegel, Erin M, additional, Teer, Jamie, additional, Hampton, Oliver, additional, Alsina, Melissa, additional, Brayer, Jason, additional, Blue, Brandon J., additional, Siqueira Silva, Ariosto, additional, Baz, Rachid, additional, Nishihori, Taiga, additional, and Shain, Kenneth H., additional

Published
2021
Full Text
View/download PDF

37. spatialTIME and iTIME: R package and Shiny application for visualization and analysis of immunofluorescence data

Author

Creed, Jordan H, primary, Wilson, Christopher M, additional, Soupir, Alex C, additional, Colin-Leitzinger, Christelle M, additional, Kimmel, Gregory J, additional, Ospina, Oscar E, additional, Chakiryan, Nicholas H, additional, Markowitz, Joseph, additional, Peres, Lauren C, additional, Coghill, Anna, additional, and Fridley, Brooke L, additional

Published
2021
Full Text
View/download PDF

40. Genital Powder Use and Risk of Epithelial Ovarian Cancer in the Ovarian Cancer in Women of African Ancestry Consortium

Author

Davis, Colette P., primary, Bandera, Elisa V., additional, Bethea, Traci N., additional, Camacho, Fabian, additional, Joslin, Charlotte E., additional, Wu, Anna H., additional, Beeghly-Fadiel, Alicia, additional, Moorman, Patricia G., additional, Myers, Evan R., additional, Ochs-Balcom, Heather M., additional, Peres, Lauren C., additional, Rosenow, Will T., additional, Setiawan, Veronica W., additional, Rosenberg, Lynn, additional, Schildkraut, Joellen M., additional, and Harris, Holly R., additional

Published
2021
Full Text
View/download PDF

42. Selinexor Disrupts Epigenetic Programing and Modulates Immunogenicity in Multiple Myeloma

Author

Sudalagunta, Praneeth Reddy, Renatino-Canevarolo, Rafael, Meads, Mark B, Noyes, David, Achille, Alexandra, Silva, Maria, Zhao, Xiaohong, Alugubelli, Raghunandan Reddy, Lastorino, Daniel, Hampton, Oliver, Freeman, Ciara Louise L., Wu, Stephen, Ellero, Andrea, Peres, Lauren C., Hansen, Doris K., Mark, Tomer, Walker, Christopher J., Taverna, Pietro, Baz, Rachid, Shain, Kenneth, and Siqueira Silva, Ariosto

Published
2023
Full Text
View/download PDF

43. A Pro-Inflammatory State and Peak Cytokines Are Associated with Toxicity and Early Responses in Real-World Multiple Myeloma Patients Treated with Idecabtagene Vicleucel

Author

Hansen, Doris K., Peres, Lauren C., Abraham Miranda, Julieta, Reid, Kayla, De Avila, Gabriel, Huggar, David, Patwardhan, Pallavi, Oswald, Laura B., Grajales-Cruz, Ariel F., Blue, Brandon, Liu, Hien, Nishihori, Taiga, Shain, Kenneth, Baz, Rachid, Alsina, Melissa, Castaneda, Omar, Tiwana, Simran K., Botros, Afraim, Locke, Frederick L., and Freeman, Ciara Louise L.

Published
2023
Full Text
View/download PDF

44. Facility-Related Healthcare Resource Utilization (HCRU) for Patients Treated with Idecabtagene Vicleucel (Ide-Cel, bb2121) in a Real-World (RW) Setting: A Single-Center Experience

Author

Peres, Lauren C., Patwardhan, Pallavi, Huggar, David, De Avila, Gabriel, Oswald, Laura B., Grajales-Cruz, Ariel F., Blue, Brandon, Abraham Miranda, Julieta, Reid, Kayla, Liu, Hien, Nishihori, Taiga, Shain, Kenneth H., Baz, Rachid, Alsina, Melissa, Castaneda, Omar, Locke, Frederick L., Freeman, Ciara Louise L., Tiwana, Simrandeep, Botros, Afraim, and Hansen, Doris K.

Published
2023
Full Text
View/download PDF

46. Racial Differences in Population Attributable Risk for Epithelial Ovarian Cancer in the OCWAA Consortium

Author

Peres, Lauren C, primary, Bethea, Traci N, additional, Camacho, Tareq F, additional, Bandera, Elisa V, additional, Beeghly-Fadiel, Alicia, additional, Chyn, Deanna L, additional, Harris, Holly R, additional, Joslin, Charlotte E, additional, Moorman, Patricia G, additional, Myers, Evan, additional, Ochs-Balcom, Heather M, additional, Rosenow, Will, additional, Setiawan, V Wendy, additional, Wu, Anna H, additional, Rosenberg, Lynn, additional, and Schildkraut, Joellen M, additional

Published
2020
Full Text
View/download PDF

47. Abstract 1180: Estimating the contribution of epidemiologic risk factors to racial differences in epithelial ovarian cancer incidence

Author

Peres, Lauren C., primary, Camacho, Tareq F., additional, Bandera, Elisa V., additional, Bethea, Traci N., additional, Joslin, Charlotte E., additional, Wu, Anna H., additional, Beeghly-Fadiel, Alicia, additional, Cloyd, Emily K., additional, Harris, Holly R., additional, Moorman, Patricia G., additional, Myers, Evan, additional, Ochs-Balcom, Heather M., additional, Rosenow, Will L., additional, Setiawan, Veronica W., additional, Rosenberg, Lynn, additional, and Schildkraut, Joellen M., additional

Published
2020
Full Text
View/download PDF

48. Abstract C070: Racial disparities in body mass index and ovarian cancer risk in the OCWAA Consortium

Author

Bandera, Elisa V, primary, Camacho, Fabian, additional, Chyn, Deanna, additional, Cloyd, Emily K, additional, Bethea, Traci N, additional, Beeghly-Fadiel, Alicia, additional, Joslin, Charlotte E, additional, Myers, Evan, additional, Moorman, Patricia G, additional, Ochs-Balcom, Heather M, additional, Harris, Holly R, additional, Peres, Lauren C, additional, Setiawan, Veronica Wendy, additional, Wu, Anna H, additional, Rosenberg, Lynn, additional, and Schildkraut, Joellen M, additional

Published
2020
Full Text
View/download PDF

49. Abstract C038: First- and second-degree family history of ovarian and breast cancers in relation to risk of invasive ovarian cancer in African American and White women

Author

Bethea, Traci N., primary, Ochs-Balcom, Heather M., additional, Bandera, Elisa V., additional, Beeghly-Fadiel, Alicia, additional, Camancho, Fabian, additional, Cloyd, Emily K., additional, Harris, Holly R., additional, Joslin, Charlotte E., additional, Myers, Evan, additional, Moorman, Patricia G., additional, Peres, Lauren C., additional, Setiawan, Veronica W., additional, Wu, Anna H., additional, Rosenberg, Lynn, additional, and Schildkraut, Joellen M., additional

Published
2020
Full Text
View/download PDF

50. The Deepwater Horizon Oil Spill and physical health among adult women in southern Louisiana: The Women and Their Children's Health (WaTCH) Study

Author

Peres, Lauren C., Trapido, Edward, Rung, Ariane L., Harrington, Daniel J., Oral, Evrim, Fang, Zhide, Fontham, Elizabeth, and Peters, Edward S.

Subjects
British Petroleum Company PLC -- Casualties, Deepwater drillships -- Casualties, Petroleum industry -- Casualties, Oil spills -- Analysis -- Health aspects -- Risk factors, Women's health -- Analysis -- Health aspects, Environmental toxicology -- Analysis -- Health aspects, Environmental issues, Health
Abstract

BACKGROUND: The Deepwater Horizon Oil Spill (DHOS) is the largest oil spill in U.S. history, negatively impacting Gulf Coast residents and the surrounding ecosystem. To date, no studies have been published concerning physical health outcomes associated with the DHOS in the general community. OBJECTIVES: We characterized individual DHOS exposure using survey data and examined the association between DHOS exposure and physical health. METHODS: Baseline data from 2,126 adult women residing in southern Louisiana and enrolled in the Women and Their Children's Health study were analyzed. Exploratory factor analysis was used to characterize DHOS exposure. Odds ratios and 95% confidence intervals for the associations between DHOS exposure and physical health symptoms were estimated using multivariate logistic regression. RESULTS: A two-factor solution was identified as the best fit for DHOS exposure: physical-environmental exposure and economic exposure. High physical-environmental exposure was significantly associated with all of the physical health symptoms, with the strongest associations for burning in nose, throat, or lungs (OR = 4.73; 95% CI: 3.10, 7.22), sore throat (OR = 4.66; 95% CI: 2.89, 7.51), dizziness (OR = 4.21; 95% CI: 2.69, 6.58), and wheezing (OR = 4.20; 95% CI: 2.86, 6.17). Women who had high-economic exposure were significantly more likely to report wheezing (OR = 1.92; 95% CI: 1.32, 2.79); headaches (OR = 1.81; 95% CI: 1.41, 2.58); watery, burning, itchy eyes (OR = 1.61; 95% CI: 1.20, 2.16); and stuffy, itchy, runny nose (OR = 1.56; 95% CI: 1.16, 2.08). CONCLUSIONS: Among southern Louisiana women, both physical-environmental and economic exposure to the DHOS were associated with an increase in self-reported physical health outcomes. Additional longitudinal studies of this unique cohort are needed to elucidate the impact of the DHOS on short- and long-term human health. http://dx.doi.org/10.1289/ehp.1510348, Introduction On 20 April 2010, the British Petroleum (BP) Deepwater Horizon drilling rig exploded off the coast of Louisiana, killing 11 workers (National Commission on the BP Deepwater Horizon Oil [...]

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results